HomeAI · summaries
Storia in 2 fonti
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observations
Aurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducted this routine inspection from August 17-21, 2026. Four procedural observations were noted during the Seymour, USA facility's review. The company will provide its response to the USFDA within the required timeframe.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindu.com
U.S. FDA flags Aurobindo arm’s Hyderabad plant
Aurobindo Pharma's Hyderabad plant receives one U.S. FDA observation regarding facility maintenance, with corrective actions already in progress.
- ·
economictimes.indiatimes.com
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observations
Aurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducted this routine inspection from August…
